Efficacy and safety of treatment with interferon-a2b plus ribavirin in children with chronic hepatitis C

被引：0
|
作者：
Mozer-Lisewska, I. [1 ]
机构：
[1] Univ Med Sci, Dept Infect Dis & Child Neurol, PL-60572 Poznan, Poland
来源：
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2006年 / 3卷 / 06期
关键词：
children; chronic hepatitis C; combination therapy; interferon-alpha; 2b; ribavirin;
D O I：
10.1038/ncpgasthep0495
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：316 / 317
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of pegylated interferon alpha-2b and ribavirin in chronic hepatitis C in children
    Kups-Rzepecka, Joanna
    Golabek, Violetta
    Kicinski, Przemyslaw
    Wozniakowska-Gesicka, Teresa
    PRZEGLAD GASTROENTEROLOGICZNY, 2010, 5 (06): : 341 - 348
  • [2] Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic hepatitis C in children
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    MEDICAL SCIENCE MONITOR, 2010, 16 (12): : CR616 - CR621
  • [3] Efficacy and Safety of Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta-analysis
    Druyts, Eric
    Thorlund, Kristian
    Wu, Ping
    Kanters, Steve
    Yaya, Sanni
    Cooper, Curtis L.
    Mills, Edward J.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (07) : 961 - 967
  • [4] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [5] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [6] Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients
    Lee, Seok
    Kim, In Hee
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    Lee, Chang Seop
    Choi, Chang Soo
    Cho, Eun Young
    Kim, Haak Cheoul
    INTERVIROLOGY, 2010, 53 (03) : 146 - 153
  • [7] Assessment of efficacy and safety of PEGylated interferon plus ribavirin in elderly patients with chronic hepatitis C
    Wen, Shi-Chi
    Cheng, Lung-Chih
    Hsu, Jui-Hung
    Lai, Hsin-Wen
    Shih, Pei-Chen
    Tsai, Chi-Chang
    Lee, Ching-Chang
    Kuo, Wu-Hsien
    ADVANCES IN DIGESTIVE MEDICINE, 2018, 5 (03) : 84 - 92
  • [8] Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C
    Hu, C. -C.
    Lin, C. -L.
    Kuo, Y. -L.
    Chien, C. -H.
    Chen, S. -W.
    Yen, C. -L.
    Lin, C. -Y.
    Chien, R. -N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 81 - 90
  • [9] Factors Influencing Treatment Efficacy of 24-Week Combination Therapy with Interferon α-2b Plus Ribavirin for Chronic Hepatitis C
    Mitsuhiko Moriyama
    Hiroshi Matsumura
    Kazushige Nirei
    Yasuo Arakawa
    Hiroaki Yamagami
    Masahiro Ogawa
    Miki Kaneko
    Shuichi Matsuoka
    Shuichi Amaki
    Naohide Tanaka
    Yasuyuki Arakawa
    Digestive Diseases and Sciences, 2007, 52 : 2418 - 2426
  • [10] Efficacy of Conventional Interferon alpha-2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients
    Farooqi, Javed Iqbal
    Farooqi, Rukhsana Javed
    RAWAL MEDICAL JOURNAL, 2005, 30 (01):
12345